LIPOTYPE GMBH -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 7
As coordinator: 0
As participant: 7
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 6.549.674 480.000 1
2020 0 27.435.615 1.789.448 3
2017 0 1.102.500 0 1
2016 0 23.215.937 718.968 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACADEMISCH ZIEKENHUIS GRONINGEN3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
NOVO NORDISK3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
UNIVERSITY OF DUNDEE3
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG2
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
ELI LILLY AND COMPANY LIMITED2
ITASUOMEN YLIOPISTO2
JDRF INTERNATIONAL2
KATHOLIEKE UNIVERSITEIT LEUVEN2
LUNDS UNIVERSITET2
SANOFIAVENTIS DEUTSCHLAND2
SIB INSTITUT SUISSE DE BIOINFORMATIQUE2
THE UNIVERSITY OF EXETER2
UNIVERSITY OF COPENHAGEN2
UNIVERSITY OF HELSINKI2
ABBVIE INC1
ACADEMISCH ZIEKENHUIS LEIDEN1
ASTELLAS PHARMA EUROPE BV1
ATTUROS LIMITED1
AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO1
BAYER PHARMA1
CAMBRIDGE EPIGENETIX LIMITED1
CENTRE HOSPITALIER INTERCOMMUNAL DE CRETEIL1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CHINO1
CHRONOS BIOSYSTEMS1
CHU HOPITAUX DE BORDEAUX1
CONSIGLIO NAZIONALE DELLE RICERCHE1
DANISH CANCER SOCIETY1
DATA MINING INTERNATIONAL1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ELI LILLY AND COMPANY1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL1
FONDAZIONE TELETHON1
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DOCTOR JOSEP TRUETA1
FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA1
GENOMED DIAGNOSTICOS DE MEDICINA MOLECULAR1
GEORGE WASHINGTON UNIVERSITY CORPORATION1
GOETEBORGS UNIVERSITET1
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT1
HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMAE1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSERM TRANSFERT1
INSTITUT DE RECHERCHES SERVIER1
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES1
INSTITUTUL DE BIOCHIMIE1
INTRABIO1
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI1
JANSSEN PHARMACEUTICA NV1
KADUCE+1
KLINIKUM DER UNIVERSITAET REGENSBURG1
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN1
LAURENT NIDDAM EUROPAI KOZOSSEGI JOGASZ IRODA1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
LUND UNIVERSITY1
MACCABI SHEIRUTEI BRIUT FOUNDATION1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MEDIZINISCHE UNIVERSITAET WIEN1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
MEDTRONIC INTERNATIONAL TRADING SARL1
METABOLON1
NEC LABORATORIES EUROPE1
NUROMEDIA1
OBESITAS NEDERLAND BV1
OBESITY ACTION COALITION INC1
PFIZER LIMITED1
PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE1
PROTOBIOS OU1
SCIPROM SARL1
SIB SWISS INSTITUTE OF BIOINFORMATICS1
SPINVERSE OY1
STEINBEIS FUNDATION1
STICHTING VUMC1
T1D EXCHANGE INC1
TECHNISCHE UNIVERSITAET DRESDEN1
THE CHILDREN'S HOSPITAL OF PHILADELPHIA NON PROFIT ORG1
THE EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY IRELAND COMPANY LIMITED BY GUARANTEE1
THE REGENTS OF THE UNIVERSITY OF MICHIGAN1
THE UNIVERSITY OF SUSSEX1
THE UNIVERSITY OF TUEBINGEN1
THIRDI1
UNIVERSIDAD DE BUENOS AIRES1
UNIVERSIDAD DE NAVARRA1
UNIVERSIDAD DEL DESARROLLO1
UNIVERSITA CATTOLICA DEL SACRO CUORE1
UNIVERSITA DEGLI STUDI DI BARI ALDO MORO1
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA1
UNIVERSITA DI PISA1
UNIVERSITAET BASEL1
UNIVERSITAET ULM1
UNIVERSITAET ZUERICH1
UNIVERSITAETSKLINIKUM FREIBURG1
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF1
UNIVERSITATSKLINIKUM ERLANGEN1

Constancy:

Total number of partners: 138
Partner loyalty:
Frequent Partner: (> 2 projects): 15
Rare Partner: 123
Frequent / Rare Partner Ratio: 0.12

Project overview:

Start dateProjectacronymrolefundingpartners
2022-06-01Decision support for prediction and management of Long Covid Syndrome (LCS) Long Covidparticipant6.549.67412
2020-06-01Stratification of Obesity Phenotypes to Optimize Future Therapy SOPHIAparticipant8.301.00036
2020-03-01Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe ISLETparticipant7.999.9998
2020-01-01Impact of exposome on the course of lung diseases REMEDIAparticipant11.134.61617
2017-03-01Genetic and Small Molecule Modifiers of Lysosomal Function LysoModparticipant1.102.50014
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2016-04-01Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881 RHAPSODYparticipant8.130.00027